Aktuellt
SENASTE
Redeye comments on aXichem’s Q3 2022 report. The report did not include any surprises where sales came in at SEK0.3m (SEK3.4m) and EBIT at SEK-4.3m (SEK-3.0m). We look forward to the potential feed-additive and GRAS feed approvals during the next months and reiterate or base case of SEK24.
LÄS MER
